药学学报, 2021, 56(9): 2410-2418
引用本文:
钮敏洁, 王梦晴, 于慧, 刘鑫, 蔡皓, 曹岗, 段煜, 裴科, 张专. 基于血浆代谢组学的山茱萸酒制后抗大鼠肝纤维化作用增强机制研究[J]. 药学学报, 2021, 56(9): 2410-2418.
NIU Min-jie, WANG Meng-qing, YU Hui, LIU Xin, CAI Hao, CAO Gang, DUAN Yu, PEI Ke, ZHANG Zhuan. Mechanism investigation on the enhanced anti-hepatic fibrosis effects in rats of Fructus Corni after wine-processing based on plasma metabonomics[J]. Acta Pharmaceutica Sinica, 2021, 56(9): 2410-2418.

基于血浆代谢组学的山茱萸酒制后抗大鼠肝纤维化作用增强机制研究
钮敏洁1,2, 王梦晴1,2, 于慧1,2, 刘鑫1,2, 蔡皓1,2*, 曹岗3, 段煜1,2, 裴科4, 张专1
1. 南京中医药大学药学院, 江苏 南京 210023;
2. 南京中医药大学国家教育部中药炮制规范化及标准化工程研究中心, 江苏 南京 210023;
3. 浙江中医药大学药学院, 浙江 杭州 310053;
4. 山西中医药大学中药与食品工程学院, 山西 晋中 030619
摘要:
运用代谢组学技术探究和鉴定山茱萸生、制品提取物抗大鼠肝纤维化的作用机制及代谢通路,并比较分析酒蒸山茱萸干预大鼠肝纤维化作用增强的潜在机制。将大鼠随机分为空白对照组、模型组、秋水仙碱组、山茱萸生品低、中、高剂量组以及山茱萸制品低、中、高剂量组,每组6只。皮下注射40%四氯化碳复制肝纤维化模型,造模第3周开始灌胃给药,给药6周后取大鼠血样及肝脏,进行药效指标检测及UHPLC-Q-TOF-MS/MS分析。药效学结果表明,山茱萸生、制品均具有抗大鼠肝纤维化的作用。代谢组学分析显示,与空白对照组相比,模型组经筛选鉴定得到24种与肝纤维化相关的潜在生物标志物,主要参与初级胆汁酸代谢、甘油磷脂代谢、戊糖和葡萄糖醛酸脂代谢、视黄醇代谢、花生四烯酸代谢。山茱萸生、制品水煎液对其中的10种生物标志物有着不同程度的回调作用,且制品作用优于生品。本研究从血浆代谢的角度阐明了山茱萸酒制增效的机制,为山茱萸的进一步开发及临床应用提供理论依据。
关键词:    山茱萸生制品      肝纤维化      血浆代谢组学      作用机制     
Mechanism investigation on the enhanced anti-hepatic fibrosis effects in rats of Fructus Corni after wine-processing based on plasma metabonomics
NIU Min-jie1,2, WANG Meng-qing1,2, YU Hui1,2, LIU Xin1,2, CAI Hao1,2*, CAO Gang3, DUAN Yu1,2, PEI Ke4, ZHANG Zhuan1
1. School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China;
2. Engineering Center of State Ministry of Education for Standardization of Chinese Medicine Processing, Nanjing University of Chinese Medicine, Nanjing 210023, China;
3. School of Pharmacy, Zhejiang Chinese Medical University, Hangzhou 310053, China;
4. School of Chinese Medicine and Food Engineering, Shanxi University of Chinese Medicine, Jinzhong 030619, China
Abstract:
Metabonomics technology was employed to investigate and identify the mechanisms and metabolic pathways of the crude and wine-processed Fructus Corni extracts on anti-hepatic fibrosis effects in rats, and to compare and analyze the potential mechanism of enhanced interference of the wine-processed Fructus Corni on hepatic fibrosis effects in rats. The rats were randomly divided into the blank control group, the model group, the colchicine group, the crude Fructus Corni groups with low, medium, and high-doses, and the wine-processed Fructus Corni groups with low, medium, and high-doses, and there were six rats in each group. The hepatic fibrosis model was established by subcutaneous injection of 40% carbon tetrachloride, and the intragastric administration was performed at the third week of modeling. The blood and liver samples of rats were taken and carried out for pharmacodynamic index detection and UHPLC-Q-TOF-MS/MS analysis after intragastric administration for six weeks. The results of pharmacodynamic investigation showed that both the crude and wine-processed Fructus Corni had the effects of anti-hepatic fibrosis in rats. Metabonomics analysis indicated that, compared to the blank control group, the twenty-four potential biomarkers related to hepatic fibrosis were screened and identified in the model group, which mainly involved in primary bile acid metabolism, glycerol phospholipid metabolism, pentose and glucuronide metabolism, retinol metabolism, and arachidonic acid metabolism. The crude and wine-processed Fructus Corni extracts had different degrees of callback effects on the ten of the above potential biomarkers, and the effect of wine-processed Fructus Corni was better than that of crude one. The present study clarifies the mechanism of enhanced efficiency of wine-processed Fructus Corni from the perspective of plasma metabolism, and provides the theoretical foundation for further development and clinical application of Fructus Corni.
Key words:    crude and wine-processed Fructus Corni    hepatic fibrosis    plasma metabonomics    mechanism of action   
收稿日期: 2021-04-29
DOI: 10.16438/j.0513-4870.2021-0652
基金项目: 国家自然科学基金面上项目(82074022);江苏省研究生科研创新计划(KYCX20_1594,KYCX21_1790).
通讯作者: 蔡皓,Tel:86-25-86798281,E-mail:haocai@njucm.edu.cn
Email: haocai@njucm.edu.cn
相关功能
PDF(774KB) Free
打印本文
0
作者相关文章
钮敏洁  在本刊中的所有文章
王梦晴  在本刊中的所有文章
于慧  在本刊中的所有文章
刘鑫  在本刊中的所有文章
蔡皓  在本刊中的所有文章
曹岗  在本刊中的所有文章
段煜  在本刊中的所有文章
裴科  在本刊中的所有文章
张专  在本刊中的所有文章

参考文献:
[1] Yoo W, Lee J, Hee Noh K, et al. Progranulin attenuates liver fibrosis by downregulating the inflammatory response[J]. Cell Death Dis, 2019, 10:758.
[2] Kao AW, McKay A, Singh PP, et al. Progranulin, lysosomal regulation and neurodegenerative disease[J]. Nat Rev Neurosci, 2017, 18:325-333.
[3] Ma YX. The Theory and Experiment Research of Effect of Chinese Medicine on Liver Injury (中药抗肝损伤理论与实验研究)[D]. Nanjing:Nanjing University of Chinese Medicine, 2015.
[4] Su XW, Nong XX, Wang ZC, et al. Study on the mechanism of effective active ingredients of Huangqi on liver fibrosis[J]. Henan Tradit Chin Med (河南中医), 2021, 41:618-621.
[5] Wu GQ, Cao G, Xia YH, et al. Protective effects of processed Fructus Corni aqueous extract against carbon tetrachloride-induced acute liver injury in rats[J]. Chin Arch Tradit Chin Med (中华中医药学刊), 2014, 32:2391-2392.
[6] Zhang YM, Zhao M, Liu YY, et al. Investigation of the therapeutic effect of Yinchen Wuling Powder on CCl4-induced hepatic fibrosis in rats by 1H NMR and MS-based metabolomics analysis[J]. J Pharm Biomed, 2021, 200:114073.
[7] Zhang Y, Zhou Q, Ding X, et al. Chemical profile of Swertia mussotii Franch and its potential targets against liver fibrosis revealed by cross-platform metabolomics[J]. J Ethnopharmacol, 2021, 274:114051.
[8] Nan MJ, Tang K, Zhang HW, et al. Study on the liver-protective effects of different parts extracts of Cornus officinalis on acute liver injury model mice[J]. China Pharm (中国药房), 2018, 29:2385-2389.
[9] Zhao CX, Zhang YM, Liu HS, et al. Protective effect of total glycosides from Cornus Officinalis against acute immunologic liver injury induced by ConA in mice[J]. Chin Arch Tradit Chin Med (中华中医药学刊), 2017, 35:1968-1971.
[10] Yang GM, Zhang YL, Dai TT, et al. Protective effect of Maillard reaction products of Fructus Corni on CCl4-induced liver injury in mice[J]. Tradit Chin Drug Res Clin Pharmacol (中药新药与临床药理), 2015, 26:786-790.
[11] Li JS, Yu ZL, Wang MY, et al. Protecting effect of Fructus Corni Officinalis before and after preparation on mice acute liver damage[J]. J Nanjing Tradit Chin Med Univ (南京中医药大学学报), 2008, 24:236-238.
[12] Bi HL, Niu D, Guo C, et al. Comparative study of crude and wine-processing Corni Fructus on chemical composition and antidiabetic effects[J]. Evid Based Complement Alternat Med, 2019, 2019:3986964.
[13] Hao HM, Jia XY, Zhou HB, et al. Investigation of the anti-renal fibrosis effect of Amygdalus mongolica using metabonomics[J]. Acta Pharm Sin (药学学报), 2020, 55:2182-2190.
[14] Du K, Gao XX, Feng Y, et al. Effects of Guilingji on Kidney-Yang deficiency syndrome in rats based on serum metabolomics[J]. Acta Pharm Sin (药学学报), 2019, 54:1476-1483.
[15] Chen ZM, Hu CJ, Zheng W, et al. Overview on application of metabonomics in study on processing mechanism of traditional Chinese materia medica[J]. Chin Arch Tradit Chin Med (中华中医药学刊), 2018, 36:275-279.
[16] Qin KM, Wang B, Chen LW, et al. Perspective and application of metabonomics in modern study of traditional Chinese medicine[J]. China J Chin Mater Med (中国中药杂志), 2014, 39:3010-3017.
[17] Hu LQ, Wang YQ, Sun HJ, et al. An untargeted metabolomics approach to investigate the wine-processed mechanism of Scutellariae radix in acute lung injury[J]. J Ethnopharmacol, 2020, 253:112665.
[18] Yanguas SC, Cogliati B, Willebrords J, et al. Experimental models of liver fibrosis[J]. Arch Toxicol, 2016, 90:1025-1048.
[19] Wu X, Cao H, Zhao LF, et al. Metabolomic analysis of glycerophospholipid signatures of inflammation treated with non-steroidal anti-inflammatory drugs-induced-RAW264.7 cells using 1H NMR and U-HPLC/Q-TOF-MS[J]. J Chromatogr B, 2016, 1028:199-215.
[20] Mai DT, Yang C, Xue Y, et al. Investigation on silymarin impact on lipopolysaccharide induced inflammation model based on arachidonic acid metabolism pathway[J]. Chin J Chromatography (色谱), 2017, 35:578-586.
[21] Yoneda A, Sakai-Sawada K, Niitsu Y, et al. Vitamin A and insulin are required for the maintenance of hepatic stellate cell quiescence[J]. Exp Cell Res, 2016, 341:8-17.
[22] Shimizu H, Tsubota T, Kanki K, et al. All-trans retinoic acid ameliorates hepatic stellate cell activation via suppression of thioredoxin interacting protein expression[J]. J Cell Physiol, 2018, 233:607-616.
[23] Phillips RJ, Fortier MA, López Bernal A. Prostaglandin pathway gene expression in human placenta, amnion and choriodecidua is differentially affected by preterm and term labour and by uterine inflammation[J]. BMC Pregnancy Childbirth, 2014, 14:241.
[24] Hoxha M. A systematic review on the role of eicosanoid pathways in rheumatoid arthritis[J]. Adv Med Sci, 2018, 63:22-29.